Permanent revocation of closure directions for Company s Dahej Site
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The regulatory closure directions on Piramal Pharma's Dahej manufacturing site have been permanently revoked. This means the site is now fully cleared to operate without restrictions. Earlier, the company had faced closure directives (likely from a drug regulatory authority) that had paused operations at this facility. With the permanent revocation, all regulatory holds on the Dahej plant are lifted for good. This restores full production capacity at the site and removes a key compliance overhang.
Positive for shareholders — the Dahej site can now operate without regulatory restrictions, supporting production, revenue, and reducing earlier uncertainty around the facility's status.